Zobrazeno 1 - 10
of 21
pro vyhledávání: '"H M Chapel"'
Publikováno v:
Tissue Antigens. 15:101-103
Publikováno v:
The Journal of Immunology. 159:6236-6241
A subgroup of common variable immunodeficiency (CVID) patients have distinct clinical features, particularly granulomata splenomegaly, characteristic blood lymphocyte phenotype, and elevated circulating TNF levels. To investigate the genetic basis fo
Publikováno v:
Postgraduate Medical Journal. 71:674-677
Rheumatoid factor is a commonly requested test in the investigation of joint problems. Although the test has been found to be both sensitive and specific for rheumatoid arthritis in patients attending Rheumatology Clinics, when the test is applied to
Publikováno v:
Journal of clinical immunology. 20(2)
To compare the efficacy of immunoglobulin replacement therapy given intravenously versus subcutaneously to prevent infections in patients with primary antibody deficiency syndromes, an international, multicenter, open label, crossover study was desig
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 159(12)
A subgroup of common variable immunodeficiency (CVID) patients have distinct clinical features, particularly granulomata splenomegaly, characteristic blood lymphocyte phenotype, and elevated circulating TNF levels. To investigate the genetic basis fo
Variation in clinical practice and its effect on outcome is little known for rare diseases such as primary antibody deficiency. As part of a national audit a survey of all 30 consultant immunologists in the United Kingdom dealing with primary antibod
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9ec6f7c541793d0d4dbca4ef9ad5614
https://europepmc.org/articles/PMC1055337/
https://europepmc.org/articles/PMC1055337/
Autor:
R M, Barnes, H M, Chapel
Publikováno v:
Journal of the Royal Society of Medicine. 88(7)
Autor:
H M, Chapel, M, Lee
Publikováno v:
Clinical and experimental immunology. 97
Patients with multiple myeloma suffer from serious bacterial infections throughout the course of the disease. This is probably associated with reduced polyclonal immunoglobulin synthesis. Prophylactic intravenous immune globulin (IVIG) reduces the in
Publikováno v:
Lancet (London, England). 343(8905)
Patients with plateau-phase multiple myeloma have an increased risk of life-threatening bacterial infections and polyclonal humoral immune suppression. We conducted a randomised, double-blind, placebo-controlled, multicentre trial of intravenous immu
Autor:
V, Brennan, H M, Chapel
Publikováno v:
Immunodeficiency. 4(1-4)